Literature DB >> 9436828

Experimental model: change in the posterior fossa with surgically induced spina bifida aperta in mouse.

T Inagaki1, G C Schoenwolf, M L Walker.   

Abstract

On the basis of experimental studies on mouse embryos in which spina bifida development of the brain ventricular system. Mouse embryos were exposed and surgically treated at gestation day 12 to produce spina bifida aperta, and operated embryos were cultured exo utero in the peritoneal cavity of the pregnant dam. Embryos were harvested at gestation day 14. Open neural tube defects resulted in 7 out of 10 embryos surviving surgery. Histological examination revealed that the sizes of ventricles in both the supra- and infratentorial compartments were greatly reduced in embryos with spina bifida aperta compared with control embryos. This result supports the hypothesis that leakage of cerebrospinal fluid through the opening of the caudal spine may be a major cause of brain abnormalities in patients with myelomeningocele.

Entities:  

Mesh:

Year:  1997        PMID: 9436828     DOI: 10.1159/000121188

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  3 in total

Review 1.  Experimental models of spinal open neural tube defect and Chiari type II malformation.

Authors:  Ki-Bum Sim; Ji Yeoun Lee; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Concomitant achondroplasia and Chiari II malformation: A double-hit at the cervicomedullary junction.

Authors:  Al-Wala Awad; Kyrieckos A Aleck; Ratan D Bhardwaj
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

Review 3.  State of the art in translating experimental myelomeningocele research to the bedside.

Authors:  Lourenço Sbragia; Karina Miura da Costa; Antonio Landolffi Abdul Nour; Rodrigo Ruano; Marcelo Volpon Santos; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2021-07-31       Impact factor: 1.475

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.